Clinical Trials on Type 2 Diabetes Mellitus (T2D) in New Zealand

Total 2064 results

Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
NYU Langone Health

Completed

NYULMC CareSmarts Pilot

Diabetes | Type 2 Diabetes (T2D)

United States
Edgar National Centre for Diabetes Research
University of Otago

Unknown

LOADD (Lifestyle Over and Above Drugs in Diabetes) Study

Type 2 Diabetes Mellitus

New Zealand
North Shore Hospital, New Zealand

Completed

Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese Patients

Obesity | Type 2 Diabetes Mellitus

New Zealand
Insulet Corporation

Completed

Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes (Evolution)

Diabetes Mellitus

New Zealand
Diabetes Foundation, India
Indian Council of Medical Research

Completed

To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects.

T2DM (Type 2 Diabetes Mellitus) | Normoglycemia

India
University of Otago
Edgar National Centre for Diabetes Research

Completed

The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management

Obesity | Type 2 Diabetes Mellitus

New Zealand
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
RWTH Aachen University
Boehringer Ingelheim

Completed

Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes (EMPA)

Diabetes Mellitus Type 2 (T2DM)

Germany
NYU Langone Health

Completed

The Effectiveness of Resistance Training on Glycemic Control for Patients With Type 2 Diabetes in Cardiac Rehabilitation

Cardiovascular Disease | Type 2 Diabetes (T2DM)

United States
Bispebjerg Hospital

Completed

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study (CutDM)

Type 2 Diabetes

Denmark
Christchurch Hospital

Unknown

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Diabetes Mellitus, Type 2

New Zealand
Eli Lilly and Company

Completed

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Type 2 Diabetes

India, Mexico, New Zealand, South Africa
Zhejiang Doer Biologics Co., Ltd.

Recruiting

A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624

Healthy, Obesity, Metabolically

New Zealand
Pfizer

Completed

Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus

Diabetes Melliuts, Type 2

United States
Zafgen, Inc.

Completed

Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus | Overweight and Obesity

Australia, New Zealand
Rutgers, The State University of New Jersey

Completed

Fiber Mix and Glycemic Response

Type2 Diabetes Mellitus

United States
Diatranz Otsuka Limited

Completed

Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus

Type 1 Diabetes

New Zealand
Pfizer

Terminated

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Type 2 Diabetes Mellitus

United States
Yale University
National Center for Advancing Translational Sciences (NCATS)

Withdrawn

Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study

Diabete Type 2

United States
PegBio Co., Ltd.

Completed

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

Type2 Diabetes Mellitus

United States
Takeda

Terminated

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes (GRAND-307)

Type 2 Diabetes Mellitus

Taiwan, China, Korea, Republic of, New Zealand, Australia
Pfizer

Completed

A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

Type 2 Diabetes Patients

United States
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Recruiting

To Compare People With T2DM Who Have Double Hump Versus Who do Not Have Double Hump

Type 2 Diabetes Mellitus With Complication

India
vTv Therapeutics

Completed

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
NYU Langone Health

Terminated

Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes

Type2 Diabetes

United States
Northwell Health
Patient-Centered Outcomes Research Institute

Completed

Diabetes Management Program for Hispanic/Latino

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States
Albany Research Institute, Inc.

Completed

Blueberry Consumption and Type 2 Diabetes

Type2 Diabetes

United States
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany, New Zealand, Hungary, Czechia, Australia
Pfizer

Completed

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Boston Therapeutics
Sugardown Company Limited

Completed

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

Type2 Diabetes Mellitus

United States
Christchurch Clinical Studies Trust Ltd
Medtronic

Unknown

Assessment of Two Insulin Pump Insulin Delivery Systems in Type 1 Diabetes.

Type1diabetes

New Zealand
New York Institute of Technology
American Osteopathic Association

Recruiting

Diabetes and Osteopathic Manipulative Medicine (OMM)

Type2 Diabetes Mellitus | Osteopathy in Diseases Classified Elsewhere

United States
Blandine Laferrere
Merck Sharp & Dohme LLC

Completed

Treatment of Diabetes After Gastric Bypass With Sitagliptin (LAF33)

Type 2 Diabetes Mellitus

United States
vTv Therapeutics

Completed

A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Albert Einstein College of Medicine
Takeda

Completed

Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone

Type 2 Diabetes Mellitus

United States
Valeritas, Inc.
Integrated Medical Development

Completed

Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting (SIMPLE)

Type 2 Diabetes Mellitus

United States
Theracos

Completed

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Type2 Diabetes Mellitus

United States, Japan
Max Healthcare Insititute Limited

Completed

Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Type 2 Diabetes Mellitus in Obese

India
Mannkind Corporation

Terminated

Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Suzhou Alphamab Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate Effects of KN056 in Healthy Participants

Type 2 Diabetes

New Zealand
AstraZeneca
Eli Lilly and Company

Completed

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

Type 2 Diabetes Mellitus

United States, Mexico, India
Eli Lilly and Company

Terminated

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Sound Shore Medical Center of Westchester
Maffucci L, Rangraj M

Completed

Study of Duodenal-Jejunal Bypass(DJB) as a Potential Cure for Type 2 Diabetes Mellitus (DJB)

Type 2 Diabetes Mellitus

United States
Garvan Institute of Medical Research
Weizmann Institute of Science

Active, not recruiting

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes (PREDICT)

Type 2 Diabetes Mellitus | Pre Diabetes

Australia
Pfizer

Completed

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
The Deutsche Diabetes Forschungsgesellschaft e.V.
Algiax Pharmaceuticals GmbH

Recruiting

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes

Type2 Diabetes

Germany
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Type 2 Diabetes Mellitus

India
German Diabetes Center
Yale University

Enrolling by invitation

"The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"

Type2 Diabetes

Germany
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Recruiting

Regulation of Endogenous Glucose Production by Central KATP Channels

Glucose Metabolism Disorders | Type 2 Diabetes Mellitus | Glucose, High Blood

United States

3

Subscribe